3D total-body photography is used to detect lesions and melanoma in patients at high risk of developing skin cancer. The cost-effectiveness of this technology was examined in a recent study published in JAMA Dermatology. Roy Perlis, Editor in Chief of JAMA+ AI, joins economist Daniel Lindsay, PhD, to discuss the clinical and economic outcomes of this recent study. Related Content:

• Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma
• Can AI Improve the Cost-Effectiveness of 3D Total-Body Photography?